Home Your basket
• Nasopharyngeal tuberculos...
   Price 5.50 €
• Objective analysis of pos...
   Price 8.50 €
• Salivary gland choristoma...
   Price 5.50 €
• Combined approach (extern...
   Price 10.50 €
• Voice after supracricoid ...
   Price 10.50 €
• Sinonasal hemangiopericyt...
   Price 8.50 €
• Role of diffusion weighte...
   Price 10.50 €
• Universal hearing screeni...
   Price 10.50 €
• The EXIT procedure: Princ...
   Price 8.50 €
• Vocal and behavioral adap...
   Price 10.50 €
• Giant osteoma of the maxi...
   Price 8.50 €
• Overlay versus underlay t...
   Price 10.50 €
• Partiturogram: (New) tool...
   Price 10.50 €
• MIF in Head and Neck canc...
   Price 10.50 €
• Vocal effectiveness in sp...
   Price 10.50 €
• Interstitial brachytherap...
   Price 8.50 €
• Ectopic thyroid: A report...
   Price 8.50 €
• Nasal cutaneous cryptococ...
   Price 5.50 €
• Recurrent ameloblastoma o...
   Price 8.50 €
• A survey of current wound...
   Price 5.50 €
• Facial threads for face l...
   Price 10.50 €
• Reconstruction after tumo...
   Price 10.50 €
• Induction chemotherapy an...
   Price 10.50 €
• A histopathologic evaluat...
   Price 8.50 €
• Ossiculoplasty with hydro...
   Price 10.50 €
• Botulinum toxin, descript...
   Price 12.50 €
• A single appointment with...
   Price 8.50 €
• Herniation of the temporo...
   Price 12.50 €
• Laryngeal schwannoma: A c...
   Price 8.50 €
• Somatic tinnitus (review)...
   Price 12.50 €
• Argon Plasma Coagulation ...
   Price 5.50 €
• Extraction of the esophag...
   Price 8.50 €
• Reverse phonation: Pathol...
   Price 8.50 €
• Wegener granulomatosis mi...
   Price 14.00 €
• Why is allergic rhinitis ...
   Price 12.00 €
• Reconstruction after hemi...
   Price 14.00 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• Presentation of a prototy...
   Price 10.50 €
• Drop weld thermal injurie...
   Price 8.50 €
• Soft palate ventilation: ...
   Price 14.00 €
• Lengthening temporalis my...
   Price 10.50 €
• Evaluation in clinical pr...
   Price 10.50 €
• Mandibular reconstruction...
   Price 8.50 €
• Context influence on the ...
   Price 10.50 €
• Cowden syndrome: Otolaryn...
   Price 12.00 €
• Postural study on healthy...
   Price 10.50 €
• Acute rhinosinusitis in a...
   Price 8.50 €
• Diagnostic value of vibra...
   Price 8.50 €
• Prevalence of and risk fa...
   Price 10.50 €
• How to predict post thyro...
   Price 12.00 €
• Virtual audiovisual talki...
   Price 10.50 €
• Surgery of mucocele of th...
   Price 10.50 €
• Bilateral abductor vocal ...
   Price 14.00 €
• Oropharyngeal reconstruct...
   Price 10.50 €
• Videonystagmography and v...
   Price 10.50 €
• Validation of a self asse...
   Price 10.50 €
• Follow up of tracheostoma...
   Price 12.00 €
• Cutaneous horn of the pin...
   Price 5.50 €
• Aneurysmal bone cyst of t...
   Price 5.50 €
• Treatment of severe epist...
   Price 5.50 €
• Forcing the voice : the c...
   Price 5.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Prosthetics gains and sat...
   Price 12.50 €
• Oculo-orbital complicatio...
   Price 14.00 €
• Combined transoral and su...
   Price 10.50 €
• Aesthetic parotidectomy: ...
   Price 8.50 €
• Phonatory threshold press...
   Price 10.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• The “Deglutition Handicap...
   Price 10.50 €
• Petrosal presigmoid appro...
   Price 8.50 €
• Neurofibromatosis Type1 r...
   Price 8.50 €
• Osteoblastoma of the eth...
   Price 10.50 €
• The ENT in operations … T...
   Price 5.50 €
• Dysphagia, a geriatric po...
   Price 8.50 €
• The use of speech therapy...
   Price 10.50 €
• Bilateral and recurrent f...
   Price 5.50 €

Total Order 722.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 2 - 2004 o

ONCOLOGY

Induction chemotherapy and laryngeal preservation in pharyngolaryngeal carcinomas. Study of a 124 serie’s patients and patient’s follow up with laryngeal preservation


Authors : J. P. Bessède, D. Vinh, D. Genet, N. Khalifa, K. Aubry, B. Rhein, S. Orsel, N. Tubiana-Mathieu, P. Clavère (Limoges)

Ref. : Rev Laryngol Otol Rhinol. 2004;125,2:81-88.

Article published in french
Downloadable PDF document french



Summary : Objective: To try and determine the value of chemotherapy and its subsequent effect on laryngeal preservation in patients presenting with laryngeal and pharyngeal carcinomas. One group was initially treated with surgery and radiotherapy. The second group was treated with chemotherapy and subsequent salvage surgery and/or radiotherapy. Their survival rates and laryngeal preservation rates were compared. Patients and methods: From 251 patients the authors have retrospectively studied 124 patients with induction chemotherapy. The survival rate has been compared with a control group of 127 patients who was treated by initial surgery and radiotherapy. Results: The survival rate at 5 years for the patients initialy treated by surgery and radiotherapy was 64.1%. The survival for patients with a total clinical response following chemotherapy was 49.8% at 5 years. Survival with no total clinical response following chemotherapy treated by secondary radiotherapy was 25.7% at 3 years. The initial rate of laryngeal preservation is 32.2% but this rate fell to 22% after local recurrencies. Conclusion: The group with total clinical response after induction chemotherapy with laryngeal preservation have a non significantly difference in their survival compared with the group initially treated by surgery and radiotherapy. In contrary patients with non complete clinical response have a survival of 25.7% at 3 years. The rate of local recurrency of patients with laryngeal preservation is 32.5% and gives a finally rate of laryngeal preservation of 21%. These recurrencies decrease the survival rate.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE